The new drug saxagliptin is now registrated in Russia

Editorial team Diabetes Mellitus

The new drug saxagliptin is now registrated in Russia

Full Text:

PDF (Rus) HTML (Rus) XML (Rus)

Generate QR code

Abstract
Cited By
Scopus Cited

Abstract

23 ноября в Москве состоялся симпозиум, посвященный появлению в России нового препарата Онглиза (саксаглиптин) из группы ингибиторов дипептидилпептидазы-4 (ДПП-4).

Keywords

inhibitors, DPP-4, saxagliptin, dipeptyl peptidase-4, new drug

About the Author

Editorial team Diabetes Mellitus

Russian Federation

Review

For citations:

The new drug saxagliptin is now registrated in Russia. Diabetes mellitus. 2010;13(4):130-130. (In Russ.)

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 2072-0351 (Print)
ISSN 2072-0378 (Online)

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Diabetes mellitus

The new drug saxagliptin is now registrated in Russia

Full Text:

Abstract

Keywords

About the Author

Review

For citations:

Cookies policy